SOFA score
SOFA Score is a scoring system primarily used in the Intensive Care Unit (ICU) to track a patient's status during the stay in the hospital. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.
Overview[edit]
The SOFA Score, also known as the Sequential Organ Failure Assessment Score, is used to track a patient's status during the stay in an ICU. It is a simple, but effective method, that enables the health care providers to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.
Calculation[edit]
The SOFA Score is calculated based on six different parameters, each representing an organ system. The parameters are as follows:
- Respiratory system: This is based on the PaO2/FiO2 ratio, with a score ranging from 0 (normal) to 4 (severe dysfunction).
- Cardiovascular system: This is based on the mean arterial pressure or the use of vasopressors, with a score ranging from 0 (normal) to 4 (severe dysfunction).
- Hepatic system: This is based on the level of bilirubin in the blood, with a score ranging from 0 (normal) to 4 (severe dysfunction).
- Coagulation system: This is based on the number of platelets in the blood, with a score ranging from 0 (normal) to 4 (severe dysfunction).
- Renal system: This is based on the level of creatinine in the blood or urine output, with a score ranging from 0 (normal) to 4 (severe dysfunction).
- Neurological system: This is based on the Glasgow Coma Scale, with a score ranging from 0 (normal) to 4 (severe dysfunction).
Usage[edit]
The SOFA Score is primarily used in the ICU to determine the extent of a person's organ function or rate of failure. This can help to predict the patient's outcome and to decide on further treatment strategies.
Limitations[edit]
While the SOFA Score is a valuable tool in assessing the severity of organ dysfunction in critically ill patients, it has its limitations. It is not intended to be used as the sole criteria for diagnosing or treating a patient, but rather as a part of a comprehensive clinical assessment.
See Also[edit]
-
SOFA score
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
